Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Derfler K, Goldammer A Combined LDL-Apheresis and Statin Treatment in Homozygous and Heterozygous Familial Hyperlipoproteinaemia Journal of Clinical and Basic Cardiology 2001; 4 (2): 139-144 PDF Summary Overview
| ||||||||
Figure/Graphic 3: Hypercholesterinämie - LDL Time course of serum LDL-cholesterol levels in homozygous (n = 4) and heterozygous (n = 10) patients with familial hypercholesterolaemia undergoing LDL-apheresis treatment at weekly intervals. The recovery of LDL-cholesterol is given both the total value (mg/dl) and the percent decrease for the last 24 hours. These values were determined either without additional statin therapy for four weeks (wash-out period) or when patients were on 80 mg of atorvastatin for a four weeks. |
Figure/Graphic 3: Hypercholesterinämie - LDL
Time course of serum LDL-cholesterol levels in homozygous (n = 4) and heterozygous (n = 10) patients with familial hypercholesterolaemia undergoing LDL-apheresis treatment at weekly intervals. The recovery of LDL-cholesterol is given both the total value (mg/dl) and the percent decrease for the last 24 hours. These values were determined either without additional statin therapy for four weeks (wash-out period) or when patients were on 80 mg of atorvastatin for a four weeks. |